Paper28246014
Montelukast inhibits oxidized low-density lipoproteins (ox-LDL) induced vascular endothelial attachment: An implication for the treatment of atherosclerosis.
Di X and 2 others. Biochem Biophys Res Commun, 2017. Cited by 32 papers, by iCite.
Cite this record
ConductScience Library. Montelukast inhibits oxidized low-density lipoproteins (ox-LDL) induced vascular endothelial attachment: An implication for the treatment of atherosclerosis. Papers, record 28246014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28246014
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Montelukast inhibits oxidized low-density lipoproteins (ox-LDL) induced vascular endothelial attachment: An implication for the treatment of atherosclerosis.
- PubMed
Topics25
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acetates | Major topic |
| Endothelium, Vascular | Major topic |
| Lipoproteins, LDL | Major topic |
| Monocytes | Major topic |
| Quinolines | Major topic |
| Anti-Asthmatic Agents | |
| Atherosclerosis | |
| Blotting, Western | |
| Cell Adhesion | |
| Cell Line, Tumor | |
| Cells, Cultured | |
| Cyclopropanes | |
| Dose-Response Relationship, Drug | |
| E-Selectin | |
| Gene Expression | |
| Human Umbilical Vein Endothelial Cells | |
| Humans | |
| Kruppel-Like Transcription Factors | |
| Mitogen-Activated Protein Kinase 7 | |
| Molecular Structure | |
| Protective Agents | |
| RNA Interference | |
| Reverse Transcriptase Polymerase Chain Reaction | |
| Sulfides | |
| Vascular Cell Adhesion Molecule-1 |
Source PubMed
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41680878 | Montelukast suppresses NLRP3 inflammasome activation as a potential prophylactic agent against gout arthritis flares. | J Inflamm (Lond) | 2026 | https://conductscience.org/library/papers/41680878 | PubMed |
| 41034674 | Evaluating the role of montelukast on doxorubicin-induced cardiotoxicity in breast cancer patients. | Support Care Cancer | 2025 | https://conductscience.org/library/papers/41034674 | PubMed |
| 40418318 | Pharmacological and toxicological roles of Kruppel-like factors (KLFs) in the cardiovascular system: a review. | Mol Biol Rep | 2025 | https://conductscience.org/library/papers/40418318 | PubMed |
| 39358316 | Cysteinyl Leukotriene Receptor Antagonism by Montelukast to Treat Visual Deficits. | J Ocul Pharmacol Ther | 2024 | https://conductscience.org/library/papers/39358316 | PubMed |
| 38337010 | Montelukast, an available and safe anti-asthmatic drug, prevents maladaptive remodelling and maintains cardiac functionality following myocardial infarction. | Sci Rep | 2024 | https://conductscience.org/library/papers/38337010 | PubMed |
| 37163659 | Endothelial mechanobiology in atherosclerosis. | Cardiovasc Res | 2023 | https://conductscience.org/library/papers/37163659 | PubMed |
| 36984888 | Participation of Krüppel-like Factors in Atherogenesis. | Metabolites | 2023 | https://conductscience.org/library/papers/36984888 | PubMed |
| 36429069 | Role of Long Noncoding RNAs in the Regulation of Cellular Immune Response and Inflammatory Diseases. | Cells | 2022 | https://conductscience.org/library/papers/36429069 | PubMed |
| 35264962 | Astragaloside IV Relieves Atherosclerosis and Hepatic Steatosis via MAPK/NF-κB Signaling Pathway in LDLR-/- Mice. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35264962 | PubMed |
| 35203463 | The Role of KLF2 in the Regulation of Atherosclerosis Development and Potential Use of KLF2-Targeted Therapy. | Biomedicines | 2022 | https://conductscience.org/library/papers/35203463 | PubMed |
| 34950025 | Guanxinkang Decoction Attenuates the Inflammation in Atherosclerosis by Regulating Efferocytosis and MAPKs Signaling Pathway in LDLR-/- Mice and RAW264.7 Cells. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34950025 | PubMed |
| 34565285 | Montelukast attenuates interleukin IL-1β-induced oxidative stress and apoptosis in chondrocytes by inhibiting CYSLTR1 (Cysteinyl Leukotriene Receptor 1) and activating KLF2 (Kruppel Like Factor 2). | Bioengineered | 2021 | https://conductscience.org/library/papers/34565285 | PubMed |
| 34218304 | Comparative study evaluating antihistamine versus leukotriene receptor antagonist as adjuvant therapy for rheumatoid arthritis. | Eur J Clin Pharmacol | 2021 | https://conductscience.org/library/papers/34218304 | PubMed |
| 33519477 | Montelukast Use Decreases Cardiovascular Events in Asthmatics. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/33519477 | PubMed |
| 33392263 | The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic. | Front Mol Biosci | 2020 | https://conductscience.org/library/papers/33392263 | PubMed |
| 32990894 | LncRNA OIP5-AS1 facilitates ox-LDL-induced endothelial cell injury through the miR-98-5p/HMGB1 axis. | Mol Cell Biochem | 2021 | https://conductscience.org/library/papers/32990894 | PubMed |
| 31865360 | Oxidized Low Density Lipoprotein-Induced Atherogenic Response of Human Umbilical Vascular Endothelial Cells (HUVECs) was Protected by Atorvastatin by Regulating miR-26a-5p/Phosphatase and Tensin Homolog (PTEN). | Med Sci Monit | 2019 | https://conductscience.org/library/papers/31865360 | PubMed |
| 31410121 | miR-125a-5p inhibits the expression of NLRP3 by targeting CCL4 in human vascular smooth muscle cells treated with ox-LDL. | Exp Ther Med | 2019 | https://conductscience.org/library/papers/31410121 | PubMed |
| 31277498 | Modulation of Nitric Oxide Synthases by Oxidized LDLs: Role in Vascular Inflammation and Atherosclerosis Development. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31277498 | PubMed |
| 31263710 | Montelukast, a Cysteinyl Leukotriene Receptor 1 Antagonist, Induces M2 Macrophage Polarization and Inhibits Murine Aortic Aneurysm Formation. | Biomed Res Int | 2019 | https://conductscience.org/library/papers/31263710 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| KLF2 | 10365 | PubTator's text mining | https://conductscience.org/library/genes/10365 | NCBI Gene |
| MAPK7 | 5598 | PubTator's text mining | https://conductscience.org/library/genes/5598 | NCBI Gene |
| SELE | 6401 | PubTator's text mining | https://conductscience.org/library/genes/6401 | NCBI Gene |
| VCAM1 | 7412 | PubTator's text mining | https://conductscience.org/library/genes/7412 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28246014
GET https://conductscience.org/api/papers/v1/28246014/authors